Skip to main content
OpenTrials
Completed

NCT Number: NCT04571463

Ethyl Glucuronide in Urine Samples of Pregnant Women Within the HUS ja PHHYKY Area

In order to find how many women continue using alcohol during their pregnancies the plan is to anonymously test routine urine samples collected during pregnancies for ethylglucuronide (ETG), a metabolite of ethanol that is detectable in urine up to several days after alcohol consumptions. Altogether 600 samples are taken in the prenatal care units and the prenatal care units dedicated for the alcohol and drug abusing mothers both in the Helsinki and Lahti areas. Test results are used to estimate and compare the prevalence of severe maternal drinking in the different populations.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Fetal Alcohol Spectrum Disorders Alcohol-Induced Disorders Alcohol-Related Disorders Chemically-Induced Disorders Congenital, Hereditary, and Neonatal Diseases and Abnormalities Female Urogenital Diseases and Pregnancy Complications Fetal Diseases Pregnancy Complications Substance-Related Disorders Urogenital Diseases

Sex eligibility

Female

Study type

Observational

Primary location

HALSO-poliklinikka, Lahti, Paijat-Hame Region, Finland

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Pregnant

Exclusion criteria

-

Treatment and study plan

Primary outcomes

  1. EtG

    Time frame: Day 1

    The routine urine samples from the visitors are tested for ethyl glucuronide using dip sticks with 300ng cut off. Positve finds are confirmed in a laboratory.

Secondary outcomes

  1. Nicotine

    Time frame: Day 1

    The positive EtG urine samples and random negative urine samples from the visitors are tested for nicotine using dip sticks.

  2. Cannabis

    Time frame: Day 1

    The positive EtG urine samples and random negative urine samples from the visitors are tested for cannabis using dip sticks.

Sponsors and collaborators

Lead sponsor

Hanna Kahila

Other

Collaborators

  • Finnish Foundation for Alcohol Studies
  • Finnish Pediatric Neurology Association
  • Helsinki University Central Hospital
  • Päijänne Tavastia Central Hospital
  • Seinajoki Central Hospital

Registry information

Official study title

Etyyliglukuronidin Esiintyminen Virtsassa äitiysneuvola- ja äitiyspoliklinikkakäyntien yhteydessä HUS:n ja PHHYKY:n Alueella

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
Oct 1, 2020
Registry last updated
Nov 28, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.